Skip to main content

Find Clinical Trials

Home
Conditions
Progeria

Clinical trial condition

Progeria

Explore clinical trials studying Progeria. Study availability and eligibility vary by location and protocol.

4 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Progeria trial results

Enrolling by Invitation

Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria

NCT02579044

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Laminopathies, +4 more
Locations: Boston Children's Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Clinical Studies of Progeria

NCT00094393

Conditions: Aging, Premature, Arterial Occlusive Diseases, Arteriosclerosis, +25 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria

NCT00425607

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Hutchinson-Gilford Syndrome, +5 more
Locations: Children's Hospital Boston Boston, Massachusetts, United States

View Trial Details

Completed

A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria

NCT00879034

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Hutchinson-Gilford Syndrome, +5 more
Locations: Children's Hospital Boston Boston, Massachusetts, United States

View Trial Details